Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

5.030 UNCHANGED
Streaming Delayed Price Updated: 3:36 PM EDT, Aug 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 0
Open 5.030
Bid (Size) 4.900 (9)
Ask (Size) 5.070 (1)
Prev. Close 5.030
Today's Range 5.030 - 5.030
52wk Range 1.001 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+34.9%
+34.9%
1 Month
-9.9%
-9.9%
3 Month
+17.5%
+17.5%
6 Month
+22.4%
+22.4%
1 Year
+269.9%
+269.9%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 5.030
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 08/26/25 03:36 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 10.48B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.